Early-Life Heavy Metal Exposure: Effects on Fetal Growth, Birth Outcomes, and Offspring Health

A special issue of Toxics (ISSN 2305-6304). This special issue belongs to the section "Reproductive and Developmental Toxicity".

Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 723

Special Issue Editors


E-Mail Website
Guest Editor
Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China
Interests: cadmium; reproductive toxicology; developmental toxicology; environmental toxicology; epigenetics; heavy metals

E-Mail Website
Guest Editor
School of Life Sciences, Xiamen University, Xiamen, China
Interests: heavy metal; metal-containing nanoparticles; reproductive toxicology; developmental toxicology; environmental health

E-Mail Website
Guest Editor
Department of Environment and Health, Shanghai Jiao Tong University, Shanghai, China
Interests: reproductive health; cohort, metals; environmental exposure

Special Issue Information

Dear Colleagues,

Heavy metals are drawing increasing attention and are largely attributed to agricultural, mining, and industrial development. Human exposure to heavy metals has become ubiquitous, mainly through drinking water, smoking, and diet. Some heavy metals can (e.g., cadmium and lead) accumulate within tissues because of their long biological half-life and low biological excretion rate and have been associated with various adverse health consequences, including renal dysfunction, cardiovascular diseases, and metabolic syndrome. Previous studies have mainly focused on the health effects of contemporary heavy metal exposure. Developmental Origins of Health and Disease (DOHaD) theory indicates that exposure to adverse factors in early life may impair not only fetal growth but also the development of chronic diseases in adulthood. Gestational exposure to heavy metals is known to induce fetal growth restriction, yet the effect and mechanism of exposure to heavy metals in early life on fetal growth, birth outcomes, and the offspring's health remain unclear.

This Special Issue focuses on the effect and mechanism of early life exposure to heavy metals or metal-containing particles on birth outcomes, fetal growth, and offspring health. We expect the topics to cover a wide range of areas, including animal models and population studies that examine the effects of early life metal exposure on fetal growth and long-term health, exploring mechanisms such as the placenta/sperm–fetus–organ axis, epigenetics, and early biomarker screening for disease susceptibility, as well as discussion on advanced omics technologies, multi-omics approaches, and machine learning applications in the context of early life metal exposure. Authors are invited and welcome to submit original research papers, reviews, and short communications.

Prof. Dr. Hua Wang
Dr. Chengyong He
Dr. Yi-Xin Wang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heavy metals
  • early life
  • birth outcomes
  • fetal growth
  • offspring health
  • metal-containing nanoparticles
  • epigenetics
  • biomarker
  • omics technique
  • machine learning

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 3138 KiB  
Article
Esketamine Exposure Impairs Cardiac Development and Function in Zebrafish Larvae
by Shuo Huang, Jingyi Wang, Tingting Lin, Chengyong He and Zhiyuan Chen
Toxics 2024, 12(6), 427; https://doi.org/10.3390/toxics12060427 - 13 Jun 2024
Viewed by 396
Abstract
Esketamine is a widely used intravenous general anesthetic. However, its safety, particularly its effects on the heart, is not fully understood. In this study, we investigated the effects of esketamine exposure on zebrafish embryonic heart development. Zebrafish embryos were exposed to esketamine at [...] Read more.
Esketamine is a widely used intravenous general anesthetic. However, its safety, particularly its effects on the heart, is not fully understood. In this study, we investigated the effects of esketamine exposure on zebrafish embryonic heart development. Zebrafish embryos were exposed to esketamine at concentrations of 1, 10, and 100 mg/L from 48 h post-fertilization (hpf) to 72 hpf. We found that after exposure, zebrafish embryos had an increased hatching rate, decreased heart rate, stroke volume, and cardiac output. When we exposed transgenic zebrafish of the Tg(cmlc2:EGFP) strain to esketamine, we observed ventricular dilation and thickening of atrial walls in developing embryos. Additionally, we further discovered the abnormal expression of genes associated with cardiac development, including nkx2.5, gata4, tbx5, and myh6, calcium signaling pathways, namely ryr2a, ryr2b, atp2a2a, atp2a2b, slc8a3, slc8a4a, and cacna1aa, as well as an increase in acetylcholine concentration. In conclusion, our findings suggest that esketamine may impair zebrafish larvae’s cardiac development and function by affecting acetylcholine concentration, resulting in weakened cardiac neural regulation and subsequent effects on cardiac function. The insights garnered from this research advocate for a comprehensive safety assessment of esketamine in clinical applications. Full article
Show Figures

Figure 1

Back to TopTop